SynthesisEuropean journal of clinical pharmacology2024

Feasibility and safety of EGFR-TKI neoadjuvant therapy for EGFR-mutated NSCLC: A meta-analysis.

Zhuchen Yu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.